Clinical practice: Adult attention deficit-hyperactivity disorder

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Attention-Deficit/Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental disorder.
• Pharmacological interventions, including stimulants and atomoxetine, are common ADHD treatments.
• Existing research primarily focuses on short-term efficacy in adult ADHD populations.

Purpose of the Study:

• To evaluate the long-term efficacy and safety of stimulant and atomoxetine treatments for adult ADHD.
• To specifically assess the long-term outcomes in older adults with ADHD.

Main Methods:

• Review of existing literature on stimulant and atomoxetine use in adult ADHD.
• Analysis of data from short-term clinical trials.
• Identification of gaps in long-term data, particularly for geriatric populations.

Main Results:

• Short-term trials demonstrate significant ADHD symptom reduction with both medication classes.
• Limited data exists regarding the sustained benefits of these treatments over extended periods.
• Insufficient evidence is available on the long-term safety profile, especially in older adults.

Conclusions:

• While short-term ADHD treatment with stimulants and atomoxetine is effective, long-term data is lacking.
• Further research is crucial to understand the long-term benefits and risks of these ADHD medications.
• Special attention is needed for the older adult population due to insufficient long-term data.